|
|
Article: VERONA PHARMA PLC - RPL554 proven safe and effective in patients with asthma.
- Article from:
- PR Newswire UK Disclose
- Article date:
- September 11, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
11 September 2009
Verona Pharma plc
("Verona Pharma" or the "Company")
A single dose of RPL554 is safe and effective in patients with asthma
Verona Pharma plc, the AIM-quoted drug discovery company, announces the final
results of its clinical Phase I/IIa trial recently completed at the Centre for
Human Drug Research, Leiden, The Netherlands. The study was designed to
ascertain whether a safe dose of RPL554, given by inhalation to a group of
clinically stable mildly asthmatic patients that were not on maintenance
anti-asthma therapy, produced ...
Related newspaper, magazine, and journal articles:
|
|
Article: VERONA PHARMA PLC - Proposed Placing and ...
PR Newswire UK Disclose;
December 17, 2007 ;
700+ words
...VERONA PHARMA PLC ("Verona Pharma" or the "Company ... Professor Clive Page, Chairman, Verona Pharma plc: 07971 504 931 David Youngman ... 2666 Background information About Verona Pharma plc Verona Pharma is an AIM-quoted ...
|
|